Publication | Closed Access

A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease

Prolonged Event-free SurvivalCell TherapyTransplantationMarrow TransplantationRefractory HodgkinStem Cell TransplantationImmunologyHematologyGraft SurvivalBlood TransplantationImmunotherapyMedicineCell TransplantationPrognostic Model